PMID- 28561280 OWN - NLM STAT- MEDLINE DCOM- 20170731 LR - 20170731 IS - 1365-3083 (Electronic) IS - 0300-9475 (Linking) VI - 86 IP - 2 DP - 2017 Aug TI - Anti-FcgammaRIIB (CD32) Antibodies Differentially Modulate Murine FVIII-Specific Recall Response in vitro. PG - 91-99 LID - 10.1111/sji.12573 [doi] AB - Fc gamma receptors (FcgammaRs) for IgG regulate adaptive immune responses by modulating activating and inhibitory signalling pathways within immune cells. Data from a haemophilia A mouse model demonstrate that genetic deletion or blockade of the inhibitory FcgammaR (CD32) suppresses the formation of antibody-secreting cells (ASCs) in vitro. Mechanisms preventing the FVIII-specific recall response, however, remain unclear. Here, the potential role of CD32 inhibition was studied by differentially modulating receptor activity with selected anti-CD32 monoclonal antibodies (mAbs). Splenocytes from immunized FVIII(-/-) mice were restimulated with FVIII in the absence or presence of different anti-CD32 mAbs over 6 days. At day 6, cytokine release was quantified from cell culture supernatant and the formation of FVIII-specific ASCs assessed. Binding of FVIII-containing immune complexes (F8-ICs) to bone marrow-derived dendritic cells (BMdDCs) was also investigated. The antagonistic CD32 mAb AT128 suppressed the formation of FVIII-specific ASCs and reduced secretion of IFN-gamma and IL-10. In contrast, the agonistic mAbs AT130-2 and AT130-5, and their F(ab')(2) fragments, allowed the formation of FVIII-specific ASCs, even though the full IgG of AT130-2 reduced binding of F8-ICs to CD32. Data suggest that an inhibitory signal is transmitted when F8-ICs bind to CD32 and that this signal is required during memory B cell (MBC) activation to support formation of FVIII-specific ASCs. If the inhibitory signal is lacking due to CD32 deletion or blockade with antagonistic anti-CD32 mAbs, FVIII-specific T cell stimulation and ASC formation are suppressed, whereas agonistic stimulation of CD32 restores T cell stimulation and ASC formation. CI - (c) 2017 The Foundation for the Scandinavian Journal of Immunology. FAU - Vollack, N AU - Vollack N AUID- ORCID: 0000-0002-0844-6408 AD - Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. FAU - Friese, J AU - Friese J AD - Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. FAU - Bergmann, S AU - Bergmann S AD - Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. FAU - Cragg, M S AU - Cragg MS AD - Antibody and Vaccine Group, Cancer Science Unit, Faculty of Medicine, General Hospital, University of Southampton, Southampton, UK. FAU - Tiede, A AU - Tiede A AD - Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. FAU - Werwitzke, S AU - Werwitzke S AD - Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. LA - eng PT - Journal Article PL - England TA - Scand J Immunol JT - Scandinavian journal of immunology JID - 0323767 RN - 0 (Antibodies, Monoclonal) RN - 0 (Fcgr2b protein, mouse) RN - 0 (Immunoglobulin G) RN - 0 (Receptors, IgG) RN - 130068-27-8 (Interleukin-10) RN - 82115-62-6 (Interferon-gamma) RN - 9001-27-8 (Factor VIII) SB - IM MH - Animals MH - Antibodies, Monoclonal/*immunology MH - B-Lymphocytes/*immunology/metabolism MH - Bone Marrow Cells/immunology/metabolism MH - Cells, Cultured MH - Dendritic Cells/immunology/metabolism MH - Factor VIII/genetics/*immunology/metabolism MH - Flow Cytometry MH - Immunoglobulin G/immunology MH - Immunologic Memory/immunology MH - Interferon-gamma/immunology/metabolism MH - Interleukin-10/immunology/metabolism MH - Lymphocytes/immunology/metabolism MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Receptors, IgG/genetics/*immunology/metabolism MH - Spleen/cytology/immunology/metabolism MH - Time Factors EDAT- 2017/06/01 06:00 MHDA- 2017/08/02 06:00 CRDT- 2017/06/01 06:00 PHST- 2017/04/05 00:00 [received] PHST- 2017/05/18 00:00 [accepted] PHST- 2017/06/01 06:00 [pubmed] PHST- 2017/08/02 06:00 [medline] PHST- 2017/06/01 06:00 [entrez] AID - 10.1111/sji.12573 [doi] PST - ppublish SO - Scand J Immunol. 2017 Aug;86(2):91-99. doi: 10.1111/sji.12573.